← Back to Search

Behavioral Intervention

Contingency Management for Alcoholism (ARMS II Trial)

N/A
Recruiting
Led By Sterling M McPherson, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-70 years
Be older than 18 years old
Must not have
Anyone aged 71 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 months
Awards & highlights

Summary

This trial is testing a program called Contingency Management to see if it can help adults who want to drink less alcohol. It is a study where participants are randomly assigned to different groups to see if

Who is the study for?
This trial is for adults who are looking to quit or cut down on their alcohol consumption. The specific eligibility criteria have not been provided, but typically participants must meet certain health conditions and agree to follow the study's procedures.
What is being tested?
The ARMS II study is testing a behavioral treatment called Contingency Management (CM) which rewards individuals for meeting sobriety goals. It's a non-medicated approach in a randomized controlled setting to see if it helps reduce alcohol intake.
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, there may not be direct side effects like with drugs; however, participants might experience stress or frustration related to adherence to the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am 71 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in days abstinent

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency Management + Treatment As UsualExperimental Treatment1 Intervention
An experimental approach examining the effectiveness of contingency management for promoting a decrease in drinking through increasing rewards for positive behavior. Participants will be given positive reinforcement messaging regardless of the sample's results.
Group II: Non-Contingent Management + Treatment As UsualActive Control1 Intervention
Participants will be given a flat amount for submitting samples on time, and there is no increasing scale for maintaining samples at 0.00%BAC. Participants will be given positive reinforcement messaging regardless of the sample's results.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 2
~3400

Find a Location

Who is running the clinical trial?

Washington State UniversityLead Sponsor
104 Previous Clinical Trials
57,309 Total Patients Enrolled
8 Trials studying Alcoholism
1,491 Patients Enrolled for Alcoholism
Managed Health ConnectionsUNKNOWN
Sterling M McPherson, PhDPrincipal InvestigatorWashington State University
2 Previous Clinical Trials
265 Total Patients Enrolled
1 Trials studying Alcoholism
205 Patients Enrolled for Alcoholism
~83 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top